By restoring SIRT3 expression, it is possible to modulate mitochondrial function, induce apoptosis and disrupt hypoxia-driven oncogenic survival mechanisms, positioning SIRT3 as both a potent tumor suppressor and a critical biomarker for pancreatic cancer prognosis. This evidence concerns the gene SIRT3 and pancreatic neoplasm.